Valeo Pharma Inc.’s C$11.5 Million Bought Deal

Fasken advised the sole bookrunner. On June 29, 2021, Valeo Pharma Inc., a Canadian pharmaceutical company, announced the closing of its “bought deal” short form prospectus…

This content is for Standard 1 Year members only.
Login Join Now
Martina Bellini

Author: Martina Bellini

This content is for Standard 1 Year members only.
Login Join Now